(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Private Equity Industry Banner
Mouse Scroll Icon
July 2023

Alentis Therapeutics Appoints Luca Santarelli as Chairperson

Alentis Therapeutics announced the appointment of Dr. Luca Santarelli as the Chair of its Board of Directors.

Dr. Luca has been a member of Alentis’ board since 2021 and brings over 20 years of experience in academic and pharmaceutical R&D. He recently served as the founder and CEO of VectivBio AG and previously held the position of CEO and co-founder of Therachon AG, which was acquired by Pfizer.

Alentis Therapeutics is a biotechnology company specializing in the development of therapeutics for fibrotic diseases and cancer.